KR870004019A - 퀴놀린 유도체의 제조방법 - Google Patents

퀴놀린 유도체의 제조방법 Download PDF

Info

Publication number
KR870004019A
KR870004019A KR860009083A KR860009083A KR870004019A KR 870004019 A KR870004019 A KR 870004019A KR 860009083 A KR860009083 A KR 860009083A KR 860009083 A KR860009083 A KR 860009083A KR 870004019 A KR870004019 A KR 870004019A
Authority
KR
South Korea
Prior art keywords
group
formula
compound
ester
general formula
Prior art date
Application number
KR860009083A
Other languages
English (en)
Other versions
KR910006806B1 (ko
Inventor
돈이찌 마쓰모또
데루고끼 미야모또
히로시 에가와
신이찌 나까무라
Original Assignee
후지와라 도미오
다이닛뽕 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 후지와라 도미오, 다이닛뽕 세이야꾸 가부시끼가이샤 filed Critical 후지와라 도미오
Publication of KR870004019A publication Critical patent/KR870004019A/ko
Application granted granted Critical
Publication of KR910006806B1 publication Critical patent/KR910006806B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Abstract

내용 없음

Description

퀴놀린 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (1)

  1. 하기 일반식(Ⅰ)을 갖는 퀴놀린 유도체 또는 그의 에스테르 또는 이들의 염을 제조하는데 있어서,
    (식중, Z는 아미노기 또는 할로겐원자를 나타내고, R1은 수소원자, 메틸기 또는 에틸기를 타나내며, R2는 수소원자, 메틸기 또는 플루오로메틸기를 나타내고, R3및 R4는 동일하거나 다른 것으로서, 수소원자 또는 메틸기를 나타내며 및 n은 정수 1 또는 2이다) (ⅰ) 하기 일반식(Ⅱ)의 카르복실산 또는 그의 에스테르와 하기 일반식(Ⅲ)의 화합물을 반응시켜, 상기 일반식(Ⅰ)의 화합물 또는 그의 에스테르를 제조하거나,
    (식중, R1,R2,R3,R4, Z 및 n은 상술한 바와 같고, X는 할로겐원자를 나타내며, Y는 수소원자 또는 탄소수 1-5의 저급알킬기이다. 단, Z가 할로겐원자인 경우, Y는 수소원자이다) 또는, (ⅱ) 하기 일반식(Ⅳ)의 화합물과 암모니아를 반응시켜 상기 일반식(Ⅰ)의 화합물 또는 그의 에스테르를 제조하거나,
    (식중, R1,R2,R3,R4,X,Y 및 n은 상술한 바와 같다) 또는, (ⅲ) 하기 일반식(Ⅴ)의 화합물에 대하여 보호기-제거반응을 수행하여, 상기 일반식(Ⅰ)의 화합물 또는 그의 에스테르를 제조하거나,
    (식중, Z′는 아미노기, 할로겐원자 또는 보호기로 보호된 아미노기이고, R1′는 수소원자, 메틸기, 에틸기 또는 아미노기의 보호기이며, R2,R3,R4,Y 및 n은 상술한 바와 같다. 단, Z′가 아미노기 또는 할로겐 원자인 경우 R1′는 아미노기의 보호기이다) 또는, (ⅳ) 하기일반식(Ⅵ)와 에스테르를 가수분해 하여 상기 일반식(Ⅰ)의 화합물을 제조하거나,
    (식중, Y′는 탄소수 1-5의 저급 알킬기이고, R1,R2,R3,R4,Z n은 상술한 바와 같다) 또는, (ⅴ) 하기 일반식(Ⅰ)의 카르복실산을 에스테르화 시킴으로써 상기 일반식(Ⅰ) 화합물의 에스테르를 제조하거나,
    (식중, R1,R2,R3,R4,Z 및 n은 상술한 바와 같다) 또는, (ⅵ) 필요하다면, 하기 일반식(Ⅰ)의 갖는 퀴놀린 유도체 또는 그의 에스테르를 산, 염기 또는 금속염으로 처리하여 상기 일반식(Ⅰ)의 화합물 또는 그의 에스테르의 염을 제조함.
    (식중, R1,R2,R3,R4,Z 및 n은 상술한 바와 같다)을 특징으로 하는 상기 일반식(Ⅰ)을 갖는 퀴놀린 유도체의 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860009083A 1985-10-29 1986-10-29 퀴놀린 유도체의 제조방법 KR910006806B1 (ko)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
JP24225785 1985-10-29
JP60-242257 1985-10-29
JP242257 1985-10-29
JP60-285323 1985-12-17
JP285323 1985-12-17
JP28532385 1985-12-17
JP3262786 1986-02-17
JP32627 1986-02-17
JP61-32627 1986-02-17

Publications (2)

Publication Number Publication Date
KR870004019A true KR870004019A (ko) 1987-05-06
KR910006806B1 KR910006806B1 (ko) 1991-09-02

Family

ID=27287785

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860009083A KR910006806B1 (ko) 1985-10-29 1986-10-29 퀴놀린 유도체의 제조방법

Country Status (26)

Country Link
US (1) US4795751A (ko)
EP (2) EP0375658B1 (ko)
JP (2) JPS62277362A (ko)
KR (1) KR910006806B1 (ko)
CN (1) CN1009930B (ko)
AR (3) AR242031A1 (ko)
AT (2) ATE66210T1 (ko)
AU (1) AU594983B2 (ko)
CA (1) CA1340402C (ko)
DE (3) DE10075028I2 (ko)
DK (2) DK170593B1 (ko)
ES (2) ES2057197T3 (ko)
FI (1) FI87457C (ko)
GE (1) GEP19960467B (ko)
GR (1) GR3002475T3 (ko)
HU (1) HU200452B (ko)
IL (1) IL80404A (ko)
LU (2) LU88596I2 (ko)
MY (1) MY100574A (ko)
NL (2) NL970020I2 (ko)
NO (1) NO170726C (ko)
NZ (1) NZ218089A (ko)
PH (1) PH22862A (ko)
PT (1) PT83643B (ko)
SU (2) SU1635898A3 (ko)
YU (3) YU46414B (ko)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
US5563138A (en) * 1987-04-16 1996-10-08 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic compounds
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
US5164392A (en) * 1987-10-16 1992-11-17 Dainippon Pharmaceutical Co., Ltd. Quinoline derivatives and antibacterial agent containing them
IL88003A (en) * 1987-10-16 1992-11-15 Dainippon Pharmaceutical Co Quinoline derivatives,their preparation and pharmaceutical compositions containing them
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JPH0674261B2 (ja) * 1988-06-21 1994-09-21 塩野義製薬株式会社 キノロンカルボン酸誘導体
JP2709604B2 (ja) * 1988-06-29 1998-02-04 大日本製薬株式会社 マイコプラズマ汚染の防止または除去
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
FR2655545B1 (fr) 1989-12-11 1994-06-10 Rhone Poulenc Sante Nouvelle application therapeutique des derives des fluoroquinolones.
DE4019023A1 (de) * 1990-06-14 1991-12-19 Bayer Ag Verfahren zur herstellung von chinolincarbonsaeuren
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US5342846A (en) * 1990-12-05 1994-08-30 Synphar Laboratories, Inc. 7-substituted-6-fluoro-1,4-dihydro-4-oxo-quinoline-3-carboxylic acid compounds and 7-(substituted triazolyl pyrrolidin-1-yl) 4-oxoquinoline-3-carboxylic acid derivatives useful as antibacterial agents
FR2681863B1 (fr) * 1991-09-27 1995-02-03 Rhone Dpc Europ Solution de sparfloxacine sa preparation et sel la constituant.
CA2102196A1 (en) * 1992-05-26 1993-11-27 Terumitsu Kaihoh 5-aminoquinolone carboxylic acid derivative and antibacterial agent containing the same as active ingredient
WO1993025545A1 (en) * 1992-06-09 1993-12-23 Korea Research Institute Of Chemical Technology Novel quinoline derivatives and processes for preparing the same
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
US5646163A (en) * 1992-10-30 1997-07-08 The Procter & Gamble Company Quinolone 5-(N-heterosubstituted amino) antimicrobials
CN1038326C (zh) * 1993-07-20 1998-05-13 爱斯制药株式会社 5－氨基喹诺酮羧酸衍生物及其含有该衍生物作为活性成分的抗菌剂
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
DE1135132T1 (de) 1998-12-04 2002-08-22 Influx Inc Inhibitoren des multidrogentransportes
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
CN1091103C (zh) * 1999-04-02 2002-09-18 中国科学院上海药物研究所 一类喹诺酮类化合物及它的制备和其用途
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
US7973022B2 (en) 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
US20200215074A1 (en) 2017-06-22 2020-07-09 Cipla Limited Method of Treatment of Cancer
CN112870196B (zh) * 2019-11-11 2022-02-18 山东畜牧兽医职业学院 一种治疗耐药性微生物菌的组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS58174367A (ja) 1982-04-07 1983-10-13 Tanabe Seiyaku Co Ltd キノリン誘導体及びその製法
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
DE3248506A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7(alkyl-1-piperazinyl)-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3306771A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Chinoloncarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
CS274601B2 (en) * 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS60169475A (ja) * 1984-02-14 1985-09-02 Dai Ichi Seiyaku Co Ltd キノリン誘導体
EP0160578B1 (en) * 1984-02-17 1989-11-23 Daiichi Seiyaku Co., Ltd. 1,8-naphthyridine derivatives
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
ZA852369B (en) 1984-04-26 1985-12-24 Abbott Lab Quinoline antibacterial compounds
DE3420798A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3420743A1 (de) * 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS6110574A (ja) * 1984-06-25 1986-01-18 Hokuriku Seiyaku Co Ltd ６−フルオロ−１，４−ジヒドロ−４−オキソ−７−置換ピペラジニルキノリン−３−カルボン酸誘導体
IE58742B1 (en) 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
JPS6191183A (ja) * 1984-10-11 1986-05-09 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
EP0181521A1 (en) * 1984-10-19 1986-05-21 Otsuka Pharmaceutical Co., Ltd. Antimicrobial 1-substituted Phenyl-4-oxoquinoline-3-carboxylic acid compounds
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
JPS6212760A (ja) * 1984-12-14 1987-01-21 Dai Ichi Seiyaku Co Ltd １−（２−ハロゲノシクロプロピル）キノリンカルボン酸誘導体
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
JPS6259263A (ja) * 1985-09-10 1987-03-14 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
US4977154A (en) * 1985-12-12 1990-12-11 Warner-Lambert Company 5-amino and 5-hydroxy-6-fluoroquinolones as antibacterial agents
US4668680A (en) * 1985-12-12 1987-05-26 Warner-Lambert Company 5-amino-6,8-difluoroquinolones as antibacterial agents
EP0230053A3 (en) * 1986-01-17 1988-03-30 American Cyanamid Company 7-(substituted)piperazinyl-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
EP0242789A3 (en) * 1986-04-25 1990-09-05 Dainippon Pharmaceutical Co., Ltd. Novel quinoline derivates and processes for preparation thereof
GB8612137D0 (en) * 1986-05-19 1986-06-25 Fujisawa Pharmaceutical Co Quinolone compounds

Also Published As

Publication number Publication date
MY100574A (en) 1990-12-15
JPH0543551A (ja) 1993-02-23
DK170774B1 (da) 1996-01-15
FI864299A0 (fi) 1986-10-23
NO864247D0 (no) 1986-10-23
CN1009930B (zh) 1990-10-10
ATE66210T1 (de) 1991-08-15
NO170726C (no) 1992-11-25
FI87457C (fi) 1993-01-11
NO170726B (no) 1992-08-17
NL970020I1 (nl) 1997-08-01
YU46414B (sh) 1993-10-20
JPS62277362A (ja) 1987-12-02
PH22862A (en) 1989-01-19
IL80404A (en) 1990-06-10
ATE109472T1 (de) 1994-08-15
DK514586D0 (da) 1986-10-28
DE3680859D1 (de) 1991-09-19
FI87457B (fi) 1992-09-30
NL970020I2 (nl) 1998-01-05
JPH0714918B2 (ja) 1995-02-22
YU137191A (sh) 1994-01-20
NO864247L (no) 1987-04-30
PT83643B (pt) 1988-10-14
DK514586A (da) 1987-04-30
DE10075028I1 (de) 2000-12-14
GR3002475T3 (en) 1992-12-30
EP0375658A1 (en) 1990-06-27
AU594983B2 (en) 1990-03-22
JPH0541633B2 (ko) 1993-06-24
PT83643A (en) 1986-11-01
EP0221463B1 (en) 1991-08-14
AR243520A1 (es) 1993-08-31
HU200452B (en) 1990-06-28
NL300014I1 (nl) 2000-10-02
DK170593B1 (da) 1995-11-06
ES2057197T3 (es) 1994-10-16
LU90621I2 (fr) 2000-10-09
AU6427786A (en) 1987-04-30
SU1598873A3 (ru) 1990-10-07
DK25992A (da) 1992-02-28
NZ218089A (en) 1989-03-29
HUT43839A (en) 1987-12-28
FI864299A (fi) 1987-04-30
EP0221463A2 (en) 1987-05-13
CN86107491A (zh) 1987-04-29
EP0375658B1 (en) 1994-08-03
AR242031A1 (es) 1993-02-26
AR243178A1 (es) 1993-07-30
US4795751A (en) 1989-01-03
YU183586A (en) 1988-04-30
DE3650018T2 (de) 1995-01-05
NL300014I2 (nl) 2001-02-01
GEP19960467B (en) 1996-05-27
CA1340402C (en) 1999-02-23
DK25992D0 (da) 1992-02-28
DE3650018D1 (de) 1994-09-08
LU88596I2 (fr) 1995-07-10
ES2029786T3 (es) 1992-10-01
EP0221463A3 (en) 1987-12-02
DE10075028I2 (de) 2004-01-29
YU137291A (sh) 1994-01-20
IL80404A0 (en) 1987-01-30
KR910006806B1 (ko) 1991-09-02
SU1635898A3 (ru) 1991-03-15

Similar Documents

Publication Publication Date Title
KR870004019A (ko) 퀴놀린 유도체의 제조방법
KR870010005A (ko) 퀴놀린 유도체 및 그의 에스테르 또는 염의 제조법
KR850001199A (ko) 1,8-나프티리딘 유도체의 제조법
KR840000563A (ko) 세펨 화합물의 제조방법
KR860006462A (ko) 1,8-나프틸리딘 유도체, 그 에스테르 또는 그 염의 제조방법
KR920701143A (ko) S-저급지방산 글루타티온 유도체
KR850005845A (ko) 7-아미노-3-치환된-메틸-3-세펨-4-카복실산 및 그의 저급 알킬실릴 유도체의 제조방법
KR840004113A (ko) 7-아실아미노-3-세펨-4- 카르복실산 유도체의 제조방법
KR890014435A (ko) 페녹시알킬카복실산 유도체 및 이의 제조방법
KR840004080A (ko) 살리실산 유도체의 제조방법
KR890006620A (ko) 퀴놀린 유도체 및 그의 제조법
KR840007007A (ko) 플루오로메틸티오옥사세팔로스포린의 제조방법
KR840000565A (ko) 세펨 화합물의 제조방법
KR840004415A (ko) 옥사졸 유도체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
KR870003107A (ko) 키산틴 유도체의 제조방법
KR840000521A (ko) 3-메틸플라본-8-카르복실산 에스테르류의 제조방법
KR850004959A (ko) 아릴옥시-n-(아미노알킬)-1-피롤리딘 및 피페리딘 카복스 아미드 및 카보티오 아미드의 제조방법
KR840005453A (ko) 펜엠 유도체의 제조방법
KR850004743A (ko) 티아졸일 아세트산 유도체의 제조방법
KR920008050A (ko) 세펨 화합물, 이의 제조방법 및 항균제
KR830001954A (ko) 세팔로스포린 항생제
KR860006461A (ko) 항알레르기 작용을 갖는 화합물의 제조방법
KR840000578A (ko) 포스포리피드 유도체의 제조방법
KR890009896A (ko) 디옥사조신 유도체, 그의 제법 및 그를 함유하는 조성물

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060711

Year of fee payment: 16

EXPY Expiration of term